Aktis Oncology, Inc. Common stock (AKTS) — Tangible Net Worth Ratio

Latest as of March 2024: 68.5%

Aktis Oncology, Inc. Common stock (AKTS) has a Tangible Net Worth Ratio of 68.5% as of March 2024. This metric is calculated by deducting intangible assets ($13.22 Million) from net assets ($41.91 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Aktis Oncology, Inc. Common stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

68.5%
Tangible equity / total equity

Net Assets (Equity)

$41.91 Million
USD

Intangible Assets

$13.22 Million
Goodwill, patents, brand value

Total Assets

$102.60 Million
USD

Aktis Oncology, Inc. Common stock Tangible Net Worth Ratio (2013–2023)

This chart shows how Aktis Oncology, Inc. Common stock's Tangible Net Worth Ratio has changed across 19 annual periods from 2013 to 2023. As of March 2024, the ratio stands at 68.5%, reflecting net assets of $41.91 Million with intangible assets of $13.22 Million USD. See AKTS days of operational coverage to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Aktis Oncology, Inc. Common stock (2013–2023)

The table below presents the year-by-year Tangible Net Worth Ratio for Aktis Oncology, Inc. Common stock from 2013 to 2023, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Aktis Oncology, Inc. Common stock (AKTS) market capitalisation.

Year Tangible NW Ratio Net Assets (USD) Intangible Assets Total Assets Change (pp)
2023 82.3% $86.24 Million $15.24 Million $148.92 Million ▼ -9.0 pp
2022 91.3% $103.43 Million $8.99 Million $161.34 Million ▲ +0.0 pp
2021 91.3% $103.43 Million $8.99 Million $161.34 Million ▼ -8.2 pp
2021 99.5% $117.41 Million $572.00K $124.99 Million ▲ +0.8 pp
2020 98.7% $41.49 Million $544.00K $71.43 Million ▲ +0.0 pp
2020 98.7% $41.49 Million $544.00K $71.43 Million ▲ +0.2 pp
2019 98.5% $25.95 Million $388.00K $47.95 Million ▲ +0.0 pp
2019 98.5% $25.95 Million $388.00K $47.95 Million ▲ +0.4 pp
2018 98.1% $13.85 Million $264.30K $29.31 Million ▲ +0.0 pp
2018 98.1% $13.85 Million $264.30K $29.31 Million ▼ -0.5 pp
2017 98.6% $15.01 Million $206.53K $18.09 Million ▲ +0.0 pp
2017 98.6% $15.01 Million $206.53K $18.09 Million ▲ +1.3 pp
2016 97.3% $2.68 Million $71.23K $4.54 Million ▲ +0.0 pp
2015 97.3% $2.68 Million $71.23K $4.54 Million ▼ -1.9 pp
2015 99.3% $4.19 Million $31.08K $4.51 Million ▲ +0.0 pp
2014 99.3% $4.19 Million $31.08K $4.51 Million ▼ -0.7 pp
2014 100.0% $9.21K $0.00 $9.52K ▲ +0.0 pp
2013 100.0% $8.79K $0.00 $9.10K ▲ +0.0 pp
2013 100.0% $8.79K $0.00 $9.10K
pp = percentage points